193 related articles for article (PubMed ID: 2524856)
1. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat.
Dugovic C; Wauquier A; Leysen JE; Marrannes R; Janssen PA
Psychopharmacology (Berl); 1989; 97(4):436-42. PubMed ID: 2524856
[TBL] [Abstract][Full Text] [Related]
2. 5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat.
Dugovic C; Wauquier A
Eur J Pharmacol; 1987 May; 137(1):145-6. PubMed ID: 2956115
[No Abstract] [Full Text] [Related]
3. Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat.
Dugovic C; Leysen JE; Wauquier A
Neurosci Lett; 1989 Oct; 104(3):320-5. PubMed ID: 2510097
[TBL] [Abstract][Full Text] [Related]
4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
5. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
6. The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat.
Dugovic C; Leysen JE; Janssen PF; Wauquier A
Pharmacol Biochem Behav; 1989 Nov; 34(3):533-7. PubMed ID: 2516324
[TBL] [Abstract][Full Text] [Related]
7. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
Backus LI; Sharp T; Grahame-Smith DG
Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
[TBL] [Abstract][Full Text] [Related]
8. Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment.
Dugovic C; Meert TF; Ashton D; Clincke GH
Psychopharmacology (Berl); 1992; 108(3):263-70. PubMed ID: 1523277
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1-like receptor agonists enhance wakefulness.
Dzoljic MR; Ukponmwan OE; Saxena PR
Neuropharmacology; 1992 Jul; 31(7):623-33. PubMed ID: 1407402
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
De Souza RJ; Goodwin GM; Green AR; Heal DJ
Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
Glennon RA
Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
[TBL] [Abstract][Full Text] [Related]
12. Serotonin excitation of facial motoneurons: receptor subtype characterization.
Rasmussen K; Aghajanian GK
Synapse; 1990; 5(4):324-32. PubMed ID: 2360199
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion.
Di Renzo G; Amoroso S; Taglialatela M; Canzoniero L; Basile V; Fatatis A; Annunziato L
Eur J Pharmacol; 1989 Mar; 162(2):371-3. PubMed ID: 2524399
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
15. Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion.
Van de Kar LD; Lorens SA; Urban JH; Bethea CL
Neuropharmacology; 1989 Mar; 28(3):299-305. PubMed ID: 2524677
[TBL] [Abstract][Full Text] [Related]
16. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
Jackson DA; White SR
Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
[TBL] [Abstract][Full Text] [Related]
17. Chronic 5-HT2 receptor antagonist treatment alters 5-HT1A autoregulatory control of 5-HT release in rat brain in vivo.
Kidd EJ; Leysen JE; Marsden CA
J Neurosci Methods; 1990 Sep; 34(1-3):91-8. PubMed ID: 1701842
[TBL] [Abstract][Full Text] [Related]
18. Role of different serotonergic receptors in the long-lasting blood pressure depression following muscle stimulation in the spontaneously hypertensive rat.
Hoffmann P; Carlsson S; Skarphedinsson JO; Thorén P
Acta Physiol Scand; 1990 Jun; 139(2):305-10. PubMed ID: 2142373
[TBL] [Abstract][Full Text] [Related]
19. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
Clarke RW; Ogilvie J; Houghton AK
Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
[TBL] [Abstract][Full Text] [Related]
20. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]